Company patents
Kashiv BioSciences, LLC
Kashiv BioSciences, LLC's patent strategy is heavily concentrated in "Peptides & Proteins," which accounts for nearly 70% of its portfolio, showing consistent growth in 2024 (+83.3% YoY) and 2025 (+9.1% YoY) before a partial year decline in 2026. Surprisingly, despite its biotech focus, the company also maintains a significant, albeit fluctuating, interest in "Separation Processes (Filtration, Distillation)," representing over 20% of its portfolio, with a notable 150.0% YoY growth in 2025, suggesting an emphasis on manufacturing and purification technologies alongside its core drug development.
Patent Trend by Technology Area
Yearly patent publications since 2023
Product themes
Product-level themes inferred from filings since 2023, with category chips showing where each theme appears. Select a theme to filter the patents below.
49 US filings (since 2023) · 9 categories · 7 themes
Methods and systems for the efficient and scalable production, purification, and formulation of proteins and peptides, including fermentation, chromatography, and cell-based expression systems.
Design and modification of antibodies or antibody-derived fragments for targeted therapeutic intervention, including bispecific formats, Fc region modifications, and activatable constructs.
Methods and compositions for identifying, quantifying, or characterizing specific biological molecules (e.g., nucleic acids, proteins, metabolites, antibodies) or microbial species, often for diagnostic, prognostic, or quality control applications.
Development of small molecules, often bifunctional (e.g., PROTACs) or molecular glues, that induce the ubiquitin-proteasome system or autophagy to selectively degrade specific disease-causing proteins.
Delivery systems specifically engineered to administer advanced drug formulations (e.g., microparticles, biologics, extended-release systems) to achieve precise targeting, controlled release kinetics, or enhanced therapeutic efficacy within the body.
Design and engineering of proteins or peptides to directly modulate immune responses, including enhancing antigen presentation, suppressing inflammation, or activating specific immune cell types.
Design and synthesis of acyclic or carbocyclic organic compounds that selectively modulate specific biological targets or pathways for the treatment of diseases.
Patents
Showing 1-10 of 65